IL116525A0 - Piperazinedione derivatives their preparation and use - Google Patents
Piperazinedione derivatives their preparation and useInfo
- Publication number
- IL116525A0 IL116525A0 IL11652595A IL11652595A IL116525A0 IL 116525 A0 IL116525 A0 IL 116525A0 IL 11652595 A IL11652595 A IL 11652595A IL 11652595 A IL11652595 A IL 11652595A IL 116525 A0 IL116525 A0 IL 116525A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- piperazinedione derivatives
- piperazinedione
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW084113836A TW358094B (en) | 1994-12-23 | 1995-12-23 | Piperazinedione derivatives, their preparation and their use as moduators of multi-drug resistance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9426224.3A GB9426224D0 (en) | 1994-12-23 | 1994-12-23 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL116525A0 true IL116525A0 (en) | 1996-03-31 |
Family
ID=10766589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11652595A IL116525A0 (en) | 1994-12-23 | 1995-12-22 | Piperazinedione derivatives their preparation and use |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0799222A1 (en) |
| JP (1) | JPH10511384A (en) |
| CN (1) | CN1175253A (en) |
| AU (1) | AU698828B2 (en) |
| BG (1) | BG101602A (en) |
| BR (1) | BR9510410A (en) |
| CA (1) | CA2207500A1 (en) |
| CZ (1) | CZ190097A3 (en) |
| FI (1) | FI972660A (en) |
| GB (1) | GB9426224D0 (en) |
| HU (1) | HUT77943A (en) |
| IL (1) | IL116525A0 (en) |
| NO (1) | NO972937L (en) |
| NZ (1) | NZ297847A (en) |
| PL (1) | PL320916A1 (en) |
| SK (1) | SK83697A3 (en) |
| TW (1) | TW358094B (en) |
| WO (1) | WO1996020190A1 (en) |
| ZA (1) | ZA9510909B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| HUP0001531A3 (en) * | 1996-10-18 | 2000-09-28 | Xenova Ltd Slough | Anthranilic acid derivatives as multi drug resistance modulators |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| JP2002527433A (en) | 1998-10-08 | 2002-08-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotics) |
| WO2001053290A1 (en) * | 2000-01-18 | 2001-07-26 | Nippon Steel Corporation | Cell division inhibitors and process for producing the same |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| PT1529044E (en) | 2002-08-02 | 2008-01-14 | Nereus Pharmaceuticals Inc | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| CN103396372B (en) * | 2013-08-09 | 2015-05-20 | 中国科学院南海海洋研究所 | 2,5-diketopiperazine derivative, as well as preparation method and application thereof in preparing control agent for resisting marine fouling organisms |
| KR102623404B1 (en) | 2015-03-06 | 2024-01-11 | 비욘드스프링 파마수티컬스, 인코포레이티드. | How to Treat Brain Tumors |
| EP3265090A4 (en) | 2015-03-06 | 2018-08-01 | Beyondspring Pharmaceuticals Inc. | Method of treating cancer associated with a ras mutation |
| EP3334726B1 (en) | 2015-07-13 | 2022-03-16 | Beyondspring Pharmaceuticals, Inc. | Plinabulin compositions |
| MY192703A (en) | 2016-02-08 | 2022-09-02 | Beyondspring Pharmaceuticals Inc | Compositions containing tucaresol or its analogs |
| MX2018015100A (en) | 2016-06-06 | 2019-09-04 | Beyondspring Pharmaceuticals Inc | Composition and method for reducing neutropenia. |
| JP2020503363A (en) | 2017-01-06 | 2020-01-30 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | Tubulin binding compounds and their therapeutic use |
| WO2018144764A1 (en) | 2017-02-01 | 2018-08-09 | Beyondspring Pharmaceuticals, Inc. | Method of reducing neutropenia |
| KR20200112881A (en) | 2018-01-24 | 2020-10-05 | 비욘드스프링 파마수티컬스, 인코포레이티드. | Composition and method for reducing thrombocytopenia through administration of plinabulin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0649410B1 (en) * | 1992-07-10 | 1997-05-02 | Laboratoires Glaxo Sa | Anilide derivatives |
| GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
-
1994
- 1994-12-23 GB GBGB9426224.3A patent/GB9426224D0/en active Pending
-
1995
- 1995-12-21 ZA ZA9510909A patent/ZA9510909B/en unknown
- 1995-12-22 JP JP8520301A patent/JPH10511384A/en active Pending
- 1995-12-22 IL IL11652595A patent/IL116525A0/en unknown
- 1995-12-22 AU AU43100/96A patent/AU698828B2/en not_active Ceased
- 1995-12-22 NZ NZ297847A patent/NZ297847A/en unknown
- 1995-12-22 WO PCT/GB1995/003027 patent/WO1996020190A1/en not_active Application Discontinuation
- 1995-12-22 SK SK836-97A patent/SK83697A3/en unknown
- 1995-12-22 BR BR9510410-0A patent/BR9510410A/en not_active Application Discontinuation
- 1995-12-22 CZ CZ971900A patent/CZ190097A3/en unknown
- 1995-12-22 HU HU9800398A patent/HUT77943A/en unknown
- 1995-12-22 CN CN95197672A patent/CN1175253A/en active Pending
- 1995-12-22 CA CA002207500A patent/CA2207500A1/en not_active Abandoned
- 1995-12-22 PL PL95320916A patent/PL320916A1/en unknown
- 1995-12-22 EP EP95941797A patent/EP0799222A1/en not_active Withdrawn
- 1995-12-23 TW TW084113836A patent/TW358094B/en active
-
1997
- 1997-06-11 BG BG101602A patent/BG101602A/en unknown
- 1997-06-19 FI FI972660A patent/FI972660A/en unknown
- 1997-06-23 NO NO972937A patent/NO972937L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9426224D0 (en) | 1995-02-22 |
| BR9510410A (en) | 1999-09-08 |
| NZ297847A (en) | 1999-04-29 |
| FI972660A (en) | 1997-08-22 |
| NO972937D0 (en) | 1997-06-23 |
| CZ190097A3 (en) | 1998-01-14 |
| CA2207500A1 (en) | 1996-07-04 |
| NO972937L (en) | 1997-06-23 |
| BG101602A (en) | 1998-02-27 |
| FI972660A0 (en) | 1997-06-19 |
| HUT77943A (en) | 1998-12-28 |
| SK83697A3 (en) | 1998-05-06 |
| CN1175253A (en) | 1998-03-04 |
| PL320916A1 (en) | 1997-11-10 |
| TW358094B (en) | 1999-05-11 |
| AU698828B2 (en) | 1998-11-05 |
| EP0799222A1 (en) | 1997-10-08 |
| ZA9510909B (en) | 1996-08-30 |
| WO1996020190A1 (en) | 1996-07-04 |
| JPH10511384A (en) | 1998-11-04 |
| AU4310096A (en) | 1996-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL114795A0 (en) | N-benzylindole- and benmzopyrazole derivatives their preparation and use | |
| IL116851A0 (en) | 3-arylidene-2-oxindole derivatives their preparation and use | |
| IL116325A0 (en) | Substituted 1h-imidazoles their preparation and use | |
| IL115717A0 (en) | Heterocyclic compounds and their preparation and use | |
| IL118825A (en) | Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use | |
| IL120124A0 (en) | Heteroaryl-oxazolidinones their preparation and use | |
| NZ281404A (en) | Tricyclic pyrimidine derivatives and medicaments | |
| IL122215A0 (en) | Dolastatin derivatives their preparation and use | |
| IL116525A0 (en) | Piperazinedione derivatives their preparation and use | |
| IL116139A0 (en) | Pyrrole derivatives their preparation and use | |
| IL118442A0 (en) | Triazolymethyl-cyclopentanols their preparation and use | |
| ZA979175B (en) | Novel piperidineketocarboxylic acid derivatives their preparation and use | |
| GB2286393B (en) | Piperazinedione derivatives and pharmaceutical uses thereof | |
| IL118441A0 (en) | Triazolymethyl-oxiranes their preparation and use | |
| NZ332309A (en) | Alkylamino-benzothiazole and -benzoxazole derivatives and medicaments | |
| ZA973097B (en) | Novel aspire-hydroxy acid derivatives their preparation and use | |
| IL116590A0 (en) | 3-phenylisoquinol-1(2h)-one derivatives their preparation and their therapeutic application | |
| GB9617322D0 (en) | Triazine derivatives and their use | |
| ZA952410B (en) | Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals | |
| IL118443A0 (en) | Cycloalkane-benzylidene derivatives their preparation and use | |
| IL123092A0 (en) | Pyrazol-4-ylbenzoyl derivatives their preparation and use | |
| IL116014A0 (en) | Iminooxymethyleneanilides their preparation and their use | |
| IL114490A0 (en) | Heterocyclic compounds their preparation and their use | |
| IL123535A0 (en) | Benzoxazindione derivatives and their use | |
| IL122686A0 (en) | Benzylhydroxylamines their preparation and use |